Erleva 150 mg Tablet is an anticancer medicine. Cancer is an abnormal and uncontrolled multiplication of cells within the body. It is used in the treatment of patients with advanced or metastatic non-small cell lung cancer.
Erleva 150 mg Tablet is given in combination with Gemcitabine to treat pancreas cancer at the metastatic stage. Administration of this medicine may lead to kidney and liver failure. Doctors will periodically monitor kidney and liver function. Inform the physician about any history of clotting disorders or medicines taken for clotting disorders, as the Erleva 150 mg Tablet may increase the tendency to bleed.
Inform the physician if patients develop pain in the eye, blurred vision, cough, fever, shortness of breath, severe abdominal pain, and persistent diarrhea while taking this medicine. Patients are advised not to smoke while treated with this medicine, as smoking may decrease the amount of medicine in the blood. Wear protective clothing and sunscreen while going outside.
Uses of Erleva 150mg TabletAdvanced or metastatic non-small lung cancer (NSCLC)Advanced or metastatic pancreatic cancer Therapeutic Effects of Erleva 150mg Tablet
Erleva 150 mg Tablet prevents the activity of a protein called epidermal growth factor receptor (EFGR), a protein involved in the spread and growth of cancer cells. Interaction of Erleva 150mg Tablet with other drugsInform the doctor about any medications you are taking or have taken before the treatment.More Information about Erleva 150mg Tablet Keep out of sight and reach of children. Store at a controlled room temperature between 15°C to 30°C. Do not freeze.How to consume Erleva 150mg TabletAlways take this medicine as prescribed by the doctor. The tablet must be taken at least one hour before or two hours after taking food. Contact the doctor if any missed dose or taken more.Safety Advices for Erleva 150mg Tablet
Pregnancy
Taking Erleva 150 mg Tablet while pregnancy can harm the baby. Patients should not take this medicine during pregnancy unless the doctor recommends taking it. Inform your doctor if you are pregnant or planning to be pregnant before taking this medicine.
Breast Feeding
You must not take an Erleva 150 mg Tablet if the patients are breastfeeding. Consult the doctor for risks and benefits.
Lungs
This medicine is not recommended in patients with severe lung diseases. Inform the physician if the patient has any lung disorders.
Liver
This medicine is not recommended in patients with severe liver diseases. Inform the physician if the patient has any liver disorders.
Alcohol
Drinking alcohol might affect the safety or efficacy of Erleva 150 mg tablet. Consult your doctor for more advice.
Driving
No studies on the effects on the ability to drive and use machines have been performed. Erleva 150 mg tablet is not associated with mental impairment or difficulty concentrating.
Side Effects of Erleva 150mg TabletSide effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.Serious:
- Persistent or severe diarrhea
- Pain in the eye, blurred vision
- sudden difficulty in breathing accompanied by cough and fever
- severe pain in your abdomen
- liver failure
Common:
- Rash, worsened in sun-exposed areas
- Loss of appetite decreased weight
- Infection
- Headache, changes in skin sensation
- Depression
- Nausea
- Mouth irritation
- Indigestion, stomach pain, the buildup of gas
- Hair loss, dry skin, itching
- Tiredness, fever, abnormal liver function
- Inflammation around fingernail
- acne, cracked skin
- bleeding from the nose, stomach, intestines
- reduced kidney function
Word of AdviceInform the doctor if the patient has vision problems, use of contact lenses, clotting disorders, intolerance to sugar, and medication is taken for cholesterol before starting this medication. This medication should not be taken along with the food, and it can be taken either before or after food as it increases the effectiveness of the medication. It is not recommended for individuals below 18 years of age. Inform the doctor about kidney and liver disorders, as this medication is not recommended in patients with kidney and liver disorders. Avoid making plans to have children or during pregnancy because this medicine is highly unsafe and causes harmful effects on the developing baby.FAQs Q 1. How should I take an Erleva 150 mg tablet?Always take this medicine as prescribed by the doctor. The tablet must be taken at least one hour before or two hours after taking food, and it should be taken at a fixed time daily.
Q 2. Does Erleva 150 mg tablet cause eye dryness?Yes, this medication can cause eye dryness and conjunctivitis, and hence patients are advised to inform the history of vision problems and use contact lenses before taking this medication.
Q 3. Can I take an Erleva 150 mg tablet during pregnancy?This medication is highly unsafe in pregnancy as it can cause harmful effects on the developing baby. Avoid making plans to have children or during pregnancy while taking this medication.
Q 4. Can I smoke while taking the Erleva 150 mg Tablet?Avoid smoking while taking this medication, as it can decrease the effectiveness of this medication.
Q 5. How long can I take an Erleva 150 mg Tablet?Erleva 150 mg tablet is taken daily as long as prescribed by the doctor, and the duration of time varies from patient to patient depending upon the severity of the disease.
Q 6. Can Erleva 150 mg tablet be used for kidney disorders?This medication is not recommended in kidney patients as it can worsen the condition of the disease.
Fact Box of Erleva 150mg TabletMolecule name: Erlotinib | Therapeutic class: Tyrosine kinase inhibitor |
Pharmacological class: Anti-Neoplastics | Indications: 1. Advanced or metastatic non-small lung cancer (NSCLC) 2. Advanced or metastatic pancreatic cancer |
